Pnd130 - Measuring What Matters to People With Multiple Sclerosis and Preferences for Novel Methods to Assess Clinical Outcomes

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ecological Validity of Methods to Assess Walking Ability in Multiple Sclerosis

2015English

Introduction to Special Section: Measuring What Matters

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2017English

Cannabidiol to Improve Mobility in People With Multiple Sclerosis

Frontiers in Neurology
Neurology
2018English

Pnd138 - Information Searching Preferences in People With Multiple Sclerosis: The Infoseek Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Sex Matters, but to What Clinical Avail?

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2009English

The Use of Flow Cytometry to Assess a Novel Drug Efficacy in Multiple Sclerosis

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2014English

Measuring What Matters for Maternal and Newborn Health

The Lancet Global Health
Medicine
2019English

Novel Approaches to Detect Serum Biomarkers for Clinical Response to Interferon-Β Treatment in Multiple Sclerosis

PLoS ONE
Multidisciplinary
2010English

Rehabilitation to Improve Gaze and Postural Stability in People With Multiple Sclerosis: Study Protocol for a Prospective Randomized Clinical Trial

BMC Neurology
MedicineNeurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy